Teresa L. Young - Feb 4, 2022 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
EVP, Chief Commercial & Strategy Officer
Signature
/s/ Thomas J. DesRosier, attorney-in-fact for Teresa L. Young
Stock symbol
MCRB
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
4
Date filed
2/8/2022, 08:30 PM
Next filing
Feb 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (Right to Buy) Award $0 +120K $0.00 120K Feb 4, 2022 Common Stock 120K $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

EVP, Chief Commercial & Strategy Officer